Guardant Health Inc (GH)

Industry Diagnostics & Research

This stock can be held in an Investment ISA and an Investment Account
Sell

$39.00

Buy

$40.50

arrow-down$-0.26 (-0.64%)

Prices updated at 16 May 2025, 00:01 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Mr. Helmy Eltoukhy
CEO
Dr. AmirAli Talasaz
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
2,021
Head office
3100 Hanover Street
Palo Alto
United States
94304
mobile
+1 855 698-8887
letter
investors@guardanthealth.com

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Ian T. Clark
Lead Independent Director
---0.47m-
Ms. Myrtle S. Potter
Independent Director
---0.43m-
Dr. Craig Eagle, M.D.
Chief Medical Officer
-----
Ms. Vijaya Gadde
Independent Director
---0.43m-
Ms. Terilyn Juarez Monroe
Chief People Officer
0.44m--5.52m-
Mr. Steven E. Krognes, M.B.A.
Independent Director
---0.43m-
Mr. John G. Saia
Chief Legal Officer and Corporate Secretary
0.51m--3.20m-
Mr. Michael Brian Bell
Chief Financial Officer and Principal Accounting Officer
0.54m--3.61m-
Mr. Roberto A. Mignone
Independent Director
---0.73m-
Mr. Helmy Eltoukhy
Co-Chief Executive Officer and Chairman of the Board
---11.61m-
Dr. AmirAli Talasaz
Co-Chief Executive Officer and Director
---11.61m-
Ms. Meghan V. Joyce
Independent Director
---0.43m-
Dr. Manuel Hidalgo Medina, M.D.,PhD
Independent Director
---0.73m-
Mr. Kumud Kalia
Chief Information Officer
-----
Mr. Christopher Freeman
Chief Commercial Officer
-----
Mr. Musa Tariq
Independent Director
---0.43m-
Ms. Darya Chudova
Chief Technology Officer
0.49m0.04m-3.48m-

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc12,081,3770.0093288260.23916930 Apr 20259.75
BlackRock Inc11,173,8800.01-527707-4.50970530 Apr 20259.02
Wellington Management Group, LLP10,127,528-10127528-30 Apr 20258.20
Deep Track Capital, LP6,419,5667.3154190066.98278230 Apr 20255.18
Baillie Gifford & Co6,093,286--85526-1.38418230 Apr 20254.93

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
31 Dec 2024-Mr. Steven E. Krognes--2,777--
31 Dec 2024-Mr. Steven E. Krognes--10,220--
01 Jan 2025-Mr. Helmy Eltoukhy--191,978--
31 Dec 2024-Mr. Helmy Eltoukhy-----
01 Jan 2025-Mr. Helmy Eltoukhy30.551,323,0902,361,165--
01 Jan 2025-Mr. Helmy Eltoukhy--2,404,474--
31 Dec 2024-Mr. Helmy Eltoukhy30.55177,4652,309,919--
31 Dec 2024-Mr. Helmy Eltoukhy--2,315,728--
01 Jan 2025-Dr. AmirAli Talasaz--2,304,640--
01 Jan 2025-Dr. AmirAli Talasaz30.551,323,0902,261,331--
01 Jan 2025-Dr. AmirAli Talasaz--191,978--
31 Dec 2024-Dr. AmirAli Talasaz-----
31 Dec 2024-Dr. AmirAli Talasaz30.55177,4652,210,085--
31 Dec 2024-Dr. AmirAli Talasaz--2,215,894--
18 Dec 2024-Mr. Musa Tariq34.854,0432,810--
15 Dec 2024-Ms. Myrtle S. Potter--684--
15 Dec 2024-Ms. Myrtle S. Potter--13,722--
15 Dec 2024-Dr. Craig Eagle, M.D.--24,673--
15 Dec 2024-Dr. Craig Eagle, M.D.34.7624,71423,962--
15 Dec 2024-Dr. Craig Eagle, M.D.--8,411--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.